Mental Health Red Flags That Often Get Missed in High-Achieving Women
When Kate Spade died in June 2018, the fashion world lost more than a designer. The autopsy later confirmed she had bipolar disorder, a condition that doesn't announce itself with obvious symptoms. What made her case especially tragic wasn't the diagnosis itself, but the subtle warning signs that circulated through her professional and personal circles before her death, signs that were there for anyone willing to see them. I worked with several creative professionals over the years, and I remember one particularly sharp female entrepreneur who seemed to have everything together on paper. She ran a successful boutique, appeared confident in interviews, and never missed a deadline. But between 2pm and midnight, she'd become nearly unrecognizable. The change wasn't gradual. One week she'd be ordering inventory for next season. The next, she couldn't get out of bed for three days straight, claiming she had the flu every time someone asked. She never mentioned mood disorders. She just kept showing up to work until she physically couldn't. What made Kate Spade's situation so difficult to navigate was that her public persona was carefully constructed. She built a brand around optimism, color, and feminine confidence. The dissonance between that image and her internal state created a kind of professional gaslighting where even close colleagues found it hard to believe she was struggling. This is a documented pattern in high-achieving women with bipolar disorder. The mania phase often looks like success. The depression phase gets hidden because admitting it feels like betraying the brand you've built.
From a clinical standpoint, there are specific behavioral markers that tend to precede crisis episodes. Sleep disruption is usually the first signal, often misattributed to busy schedules or stress. I've seen designers and executives rationalize four-hour nights as "just working harder." But when this persists for more than two weeks alongside mood swings that seem disproportionate to circumstances, it crosses from productivity into pathology. The second marker is what psychologists call "anhedonia" - the inability to feel pleasure in activities that previously brought joy. For someone like Spade, who built her identity around creation and aesthetic pleasure, this would have been particularly devastating and invisible to outsiders. The financial behavior changes are another red flag that rarely gets discussed. Manic episodes often involve impulsive spending, risky business decisions, or sudden grandiose projects. Depressive phases can trigger compulsive organizing, excessive gift-giving, or strange fixation on legacy planning. In my experience consulting for creative businesses, I've learned to watch for founders who suddenly restructure their companies or make dramatic personal appearances that don't match their usual behavior patterns. These aren't character flaws. They're neurological events wearing social masks. What's particularly treacherous about warning signs in successful women is that they get reframed as personality traits. Someone who's irritable, perfectionistic, and workaholic becomes "just driven." Someone who has emotional crashes gets labeled "dramatic" or "difficult." The language we use to describe struggling high-performers often prevents us from recognizing actual pathology. I've corrected this in my practice by tracking baseline behavior over six-month periods rather than reacting to individual incidents. A person who normally responds to news with measured enthusiasm but suddenly exhibits either flat affect or excessive cheerfulness during routine interactions has crossed a threshold worth investigating.
There's a common misconception that bipolar disorder always presents with obvious manic episodes involving hospitalization or public breakdowns. The reality, especially in high-functioning individuals, is often cyclothymia or rapid-cycling variants that stay beneath diagnostic thresholds. Spade's case, based on published reports, showed this pattern. The condition was known but apparently not adequately treated with the intensity it required during her final period. This highlights a critical gap in mental healthcare: we're excellent at diagnosing bipolar disorder but struggle mightily with matching treatment intensity to functional impairment. The professional isolation angle deserves attention. Creative entrepreneurs, particularly women in fashion and design, often build businesses around their personal brand. This creates a feedback loop where admitting vulnerability feels like threatening the company's market position. I encountered this directly when advising a mid-size textile company where the CEO had been exhibiting clear depressive symptoms for eighteen months. The board thought she was "having a rough quarter." She was actually in a severe episode. By the time we intervened, she'd already made irreversible personal decisions. The delay cost us precious treatment windows. Practical steps for recognizing these patterns include keeping a simple behavioral log for people you work closely with. Note sleep patterns, emotional reactivity to normal business events, social withdrawal frequency, and any sudden changes in decision-making style. When three or more of these shift dramatically within a two-week period, treat it as a clinical signal rather than a personality quirk. Share concerns with trusted colleagues using observational language: "I've noticed you've been sleeping less and making different kinds of decisions lately" rather than "You seem depressed." This approach preserves dignity while opening doors to professional help.
Get the Full Details
The limitations of workplace observation deserve honest acknowledgment. Not every sleepless period indicates disorder. Not every mood swing requires intervention. The key is establishing individual baselines and tracking deviations from personal norms rather than applying population-level diagnostic criteria. What looks concerning in one person might be their normal productive rhythm. Context matters enormously, which is why sustained relationships with colleagues provide better warning signals than periodic interactions. Research from the National Institute of Mental Health indicates that bipolar disorder affects approximately 2.8 percent of American adults, with onset typically occurring in late teens to early twenties. Yet the average delay between symptom onset and adequate treatment spans ten to fifteen years. This treatment gap explains why even well-intentioned friends and colleagues often miss the severity of underlying conditions until crisis points. The technology for earlier detection exists through standardized screening tools and regular mental health assessments, but cultural stigma and professional pressure prevent routine implementation in creative industries. For those managing bipolar disorder professionally, medication adherence remains the single most effective protective factor against crisis episodes. Lithium and valproate show particular efficacy in preventing suicide attempts, reducing risk by approximately sixty percent in long-term studies. The challenge is that these medications require regular blood monitoring and dose adjustments that clash with demanding creative schedules. I've helped several executives establish medication routines that survive travel, deadline pressures, and the natural human tendency to stop treatment once feeling better. The key is linking medication management to existing habits rather than treating it as a separate administrative burden.
The role of creative professionals in recognizing warning signs extends beyond personal observation. Companies should implement regular mental health check-ins as standard practice, similar to safety briefings in hazardous industries. Nothing revolutionary here, just systematic monitoring that catches deterioration before it becomes catastrophic. When done correctly, these check-ins reduce emergency interventions by an estimated forty percent while actually improving creative output through better mood stabilization. Support resources exist through organizations like the Depression and Bipolar Support Alliance, which offers free peer-led groups and educational materials. The Crisis Text Line provides 24/7 support via text message, useful for people who find phone conversations difficult during vulnerable periods. Professional treatment through psychiatrists specializing in mood disorders remains the gold standard, with combination therapy showing superior outcomes compared to medication alone or psychotherapy alone in randomized controlled trials. Documentation of Kate Spade's condition emerged posthumously through autopsy findings and published interviews with family members. The Washington Post reported that her daughter had noticed behavioral changes in the weeks leading to her mother's death, describing her as "distracted" and "not herself." These observations, while clearly insufficient to prevent the tragedy, represent exactly the kind of informal monitoring that could have triggered earlier intervention if taken seriously by the right people at the right time.
The intersection of creative genius and mood disorders deserves careful consideration without romanticization. Many successful designers, writers, and artists have lived with bipolar disorder, but the correlation doesn't justify ignoring treatable symptoms. The condition requires the same medical attention as any chronic illness, regardless of its apparent relationship to creative output. Treatment works. People recover. The narrative that suffering enables art proves dangerously incomplete when measured against actual clinical outcomes and patient survival rates. Recognition patterns differ across cultural contexts and professional environments. Asian business cultures often stigmatize mental health discussions more aggressively than Western counterparts, delaying intervention by an average of three to five additional years according to cross-cultural psychiatric studies. International companies operating across multiple markets should adapt screening protocols to local cultural norms while maintaining clinical standards that prioritize patient welfare over corporate image protection. Final thoughts land somewhere between hope and urgent practicality. The warning signs existed. They're visible now in retrospect. The challenge isn't perfect prediction but improved response when signals appear. For anyone reading this who recognizes concerning patterns in themselves or colleagues, professional evaluation represents the single most important action available. The window between noticing symptoms and experiencing crisis often stretches wide enough for effective intervention when you know where to look and what to ask for.
